FDA PMA
FDA Class 3
Approved
🇺🇸 United States
Implant, Intragastric For Morbid Obesity
PMA: P140008
·
Supplement: S028
·
Decision Jan 5, 2026
Classifications
1
FEI Numbers
0
Registration Numbers
0
Basic Information
- Device Name
- Implant, Intragastric For Morbid Obesity
- Trade Name
- ORBERA INTRAGASTRIC BALLOON
- PMA Number
- P140008
- Supplement Number
- S028
- Device Class
- FDA Class 3
- Product Code
- LTI
- Generic Name
- IMPLANT, INTRAGASTRIC FOR MORBID OBESITY
- Medical Specialty
- Unknown
- Advisory Committee
- Gastroenterology, Urology
- Decision
- Approved
- Decision Code
- APPR
- Decision Date
- January 5, 2026
- Date Received
- November 20, 2025
- Supplement Type
- Normal 180 Day Track No User Fee
- Supplement Reason
- Location Change - Manufacturer/Sterilizer/Packager/Supplier
- Expedited Review
- N
Advisory Committee Statement
a manufacturing site change to replace the Apollo Endosurgery Coyol, Costa Rica facility with the Boston Scientific Coyol, Costa Rica facility for the Orbera Intragastric Balloon, following acquisition of Apollo Endosurgery by Boston Scientific
Classifications
This FDA Pre-Market Approval entry is associated with 1 FDA classification via its product code.
| Product Code | Device Name | Device Class | Medical Specialty |
|---|---|---|---|
| LTI | Implant, Intragastric For Morbid Obesity | FDA class 3 | Unknown |